← Browse by Condition
Medical Condition

recurrent malignant female reproductive system neoplasm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06126276 Phase 2
Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →